Most Favored Nation Pricing and Affordability of GLP-1RAs for Obesity Treatment in Medicare.

Kim DD, Hwang JH, Fendrick AM, Mozaffarian D

Open source

DOI
10.1001/jamanetworkopen.2026.13098
Published
2026 May 1
Container
JAMA network open
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1001/jamanetworkopen.2026.13098,
  title = {Most Favored Nation Pricing and Affordability of GLP-1RAs for Obesity Treatment in Medicare.},
  author = {Kim DD and Hwang JH and Fendrick AM and Mozaffarian D},
  year = {2026},
  journal = {JAMA network open},
  doi = {10.1001/jamanetworkopen.2026.13098},
  url = {https://doi.org/10.1001/jamanetworkopen.2026.13098}
}

RIS

TY  - JOUR
TI  - Most Favored Nation Pricing and Affordability of GLP-1RAs for Obesity Treatment in Medicare.
AU  - Kim DD
AU  - Hwang JH
AU  - Fendrick AM
AU  - Mozaffarian D
PY  - 2026
JO  - JAMA network open
DO  - 10.1001/jamanetworkopen.2026.13098
UR  - https://doi.org/10.1001/jamanetworkopen.2026.13098
ER  - 

APA

DD, K., JH, H., AM, F., & D, M. (2026). Most Favored Nation Pricing and Affordability of GLP-1RAs for Obesity Treatment in Medicare.. JAMA network open. https://doi.org/10.1001/jamanetworkopen.2026.13098

Source records